Veterans & TRICARE
VA and TRICARE both cover GLP-1 medications under specific criteria. Coverage is generally more expansive than commercial insurance, but criteria and pharmacies differ. Here is what currently applies.
The VA prescribes Wegovy and Zepbound through the MOVE! weight-management program after completion of behavioral counseling. Enrollment is required; eligibility follows the FDA-aligned BMI criteria. Mail-order from VA pharmacies is standard. Combat-related comorbidities (e.g., service-connected sleep apnea) often expedite approval.
TRICARE covers all four FDA-approved GLP-1 indications. Weight-management Wegovy/Zepbound requires prior authorization with BMI documentation. Pharmacy options include the Express Scripts mail-order channel, TRICARE-network retail pharmacies, and on-base military treatment facilities. Costs depend on TRICARE plan tier (Prime / Select / For Life).
Veterans not yet enrolled in VA care can apply at va.gov. Active-duty members should consult their PCM. Family members on TRICARE Select can usually obtain referrals through civilian endocrinologists or obesity-medicine specialists in-network. Telehealth GLP-1 platforms generally do not bill TRICARE — military pharmacy channels are preferred.
Yes, since 2024 Wegovy is on the VA National Formulary under the obesity-medicine pathway. Veterans must enroll in MOVE!, meet BMI criteria (≥30, or ≥27 with comorbidity), and complete behavioral counseling before pharmacotherapy.
Yes — TRICARE follows FDA-approved indications. The December 2024 Zepbound OSA expansion is covered with PA documenting moderate-to-severe AHI and obesity.
Comparison includes consultation flow, formulary, and pricing.
See top-rated providers